226 related articles for article (PubMed ID: 26561389)
1. Comparison of Three Whole-Cell Pertussis Vaccines in the Baboon Model of Pertussis.
Warfel JM; Zimmerman LI; Merkel TJ
Clin Vaccine Immunol; 2016 Jan; 23(1):47-54. PubMed ID: 26561389
[TBL] [Abstract][Full Text] [Related]
2. Lung pathology and immediate hypersensitivity in a mouse model after vaccination with pertussis vaccines and challenge with Bordetella pertussis.
Vandebriel RJ; Gremmer ER; Vermeulen JP; Hellwig SM; Dormans JA; Roholl PJ; Mooi FR
Vaccine; 2007 Mar; 25(12):2346-60. PubMed ID: 17224216
[TBL] [Abstract][Full Text] [Related]
3. Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.
Salmaso S; Mastrantonio P; Tozzi AE; Stefanelli P; Anemona A; Ciofi degli Atti ML; Giammanco A;
Pediatrics; 2001 Nov; 108(5):E81. PubMed ID: 11694665
[TBL] [Abstract][Full Text] [Related]
4. Persistence at one year of age of antigen-induced cellular immune responses in preterm infants vaccinated against whooping cough: comparison of three different vaccines and effect of a booster dose.
Vermeulen F; Dirix V; Verscheure V; Damis E; Vermeylen D; Locht C; Mascart F
Vaccine; 2013 Apr; 31(15):1981-6. PubMed ID: 23429006
[TBL] [Abstract][Full Text] [Related]
5. Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model.
Warfel JM; Zimmerman LI; Merkel TJ
Proc Natl Acad Sci U S A; 2014 Jan; 111(2):787-92. PubMed ID: 24277828
[TBL] [Abstract][Full Text] [Related]
6. Comparison of a fifth dose of a five-component acellular or a whole cell pertussis vaccine in children four to six years of age.
Halperin SA; Scheifele D; Barreto L; Pim C; Guasparini R; Medd L; Meekison W; Eastwood BJ
Pediatr Infect Dis J; 1999 Sep; 18(9):772-9. PubMed ID: 10493336
[TBL] [Abstract][Full Text] [Related]
7. Pertussis vaccination: use of acellular pertussis vaccines among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
MMWR Recomm Rep; 1997 Mar; 46(RR-7):1-25. PubMed ID: 9091780
[TBL] [Abstract][Full Text] [Related]
8. Reduced-antigen, combined diphtheria, tetanus and acellular pertussis vaccine, adsorbed (Boostrix®): a review of its properties and use as a single-dose booster immunization.
McCormack PL
Drugs; 2012 Sep; 72(13):1765-91. PubMed ID: 22931522
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity of a new enhanced tetanus-reduced dose diphtheria-acellular pertussis (Tdap) vaccine against Bordetella pertussis in a murine model.
Kang KR; Huh DH; Kim JA; Kang JH
BMC Immunol; 2021 Oct; 22(1):68. PubMed ID: 34641798
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Adenylate Cyclase Toxoid Antigen in Acellular Pertussis Vaccines by Using a Bordetella pertussis Challenge Model in Mice.
Boehm DT; Hall JM; Wong TY; DiVenere AM; Sen-Kilic E; Bevere JR; Bradford SD; Blackwood CB; Elkins CM; DeRoos KA; Gray MC; Cooper CG; Varney ME; Maynard JA; Hewlett EL; Barbier M; Damron FH
Infect Immun; 2018 Oct; 86(10):. PubMed ID: 30012638
[No Abstract] [Full Text] [Related]
11. Immunization with whole cell but not acellular pertussis vaccines primes CD4 T
Wilk MM; Borkner L; Misiak A; Curham L; Allen AC; Mills KHG
Emerg Microbes Infect; 2019; 8(1):169-185. PubMed ID: 30866771
[TBL] [Abstract][Full Text] [Related]
12. Antibody responses to Bordetella pertussis Fim2 or Fim3 following immunization with a whole-cell, two-component, or five-component acellular pertussis vaccine and following pertussis disease in children in Sweden in 1997 and 2007.
Hallander H; Advani A; Alexander F; Gustafsson L; Ljungman M; Pratt C; Hall I; Gorringe AR
Clin Vaccine Immunol; 2014 Feb; 21(2):165-73. PubMed ID: 24307240
[TBL] [Abstract][Full Text] [Related]
13. Pertussis vaccines and the challenge of inducing durable immunity.
Warfel JM; Edwards KM
Curr Opin Immunol; 2015 Aug; 35():48-54. PubMed ID: 26091979
[TBL] [Abstract][Full Text] [Related]
14. A Pertussis Outer Membrane Vesicle-Based Vaccine Induces Lung-Resident Memory CD4 T Cells and Protection Against
Zurita ME; Wilk MM; Carriquiriborde F; Bartel E; Moreno G; Misiak A; Mills KHG; Hozbor D
Front Cell Infect Microbiol; 2019; 9():125. PubMed ID: 31106160
[TBL] [Abstract][Full Text] [Related]
15. T-cell immune responses to Bordetella pertussis infection and vaccination.
Fedele G; Cassone A; Ausiello CM
Pathog Dis; 2015 Oct; 73(7):. PubMed ID: 26242279
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of experimental and commercial pertussis vaccines in the elimination of Bordetella pertussis isolates with different genetic profiles in murine model.
Prygiel M; Mosiej E; Wdowiak K; Górska P; Polak M; Lis K; Krysztopa-Grzybowska K; Zasada AA
Med Microbiol Immunol; 2021 Dec; 210(5-6):251-262. PubMed ID: 34338880
[TBL] [Abstract][Full Text] [Related]
17. What to do about pertussis vaccines? Linking what we know about pertussis vaccine effectiveness, immunology and disease transmission to create a better vaccine.
Bolotin S; Harvill ET; Crowcroft NS
Pathog Dis; 2015 Nov; 73(8):ftv057. PubMed ID: 26253079
[TBL] [Abstract][Full Text] [Related]
18. Roads to the development of improved pertussis vaccines paved by immunology.
Brummelman J; Wilk MM; Han WG; van Els CA; Mills KH
Pathog Dis; 2015 Nov; 73(8):ftv067. PubMed ID: 26347400
[TBL] [Abstract][Full Text] [Related]
19. Pertussis: Where did we go wrong and what can we do about it?
Locht C
J Infect; 2016 Jul; 72 Suppl():S34-40. PubMed ID: 27161992
[TBL] [Abstract][Full Text] [Related]
20. Do we need a new vaccine to control the re-emergence of pertussis?
Mills KH; Ross PJ; Allen AC; Wilk MM
Trends Microbiol; 2014 Feb; 22(2):49-52. PubMed ID: 24485284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
